Development of a Risk Prediction Model for Infection After Kidney Transplantation Transmitted from Bacterial Contaminated Preservation Solution

References

• Dorschner P, McElroy LM, Ison MG. Nosocomial infections within the first month of solid organ transplantation. Transpl Infect Dis. 2014;16(2):171–187. doi:10.1111/tid.12203
   PubMed Web of Science ®Google Scholar
• Avkan-Oguz V, Ozkardesler S, Unek T, et al. Risk factors for early bacterial infections in liver transplantation. Transplant Proc. 2013;45(3):993–997. doi:10.1016/j.transproceed.2013.02.067
   PubMed Web of Science ®Google Scholar
• Fishman JA. From the classic concepts to modern practice. Clin Microbiol Infect. 2014;20:4–9. doi:10.1111/1469-0691.12593
   PubMed Web of Science ®Google Scholar
• Grat M, Ligocka J, Lewandowski Z, et al. Incidence, pattern and clinical relevance of microbial contamination of preservation fluid in liver transplantation. Ann Transplant. 2012;17(3):20–28. doi:10.12659/AOT.883454
   PubMed Web of Science ®Google Scholar
• Mattana AM, Marra AR, Machado AM, et al. Evaluation of the presence of microorganisms in solid-organ preservation solution. Braz J Infect Dis. 2011;15(6):528–532. doi:10.1590/S1413-86702011000600005
   PubMed Web of Science ®Google Scholar
• Li J, Su X, Li J, et al. The association of organ preservation fluid pathogens with early infection-related events after kidney transplantation. Diagnostics. 2022;12(9):2248. doi:10.3390/diagnostics12092248
   Web of Science ®Google Scholar
• Yahav D, Manuel O. Clinical relevance of preservation-fluid contamination in solid-organ transplantation: a call for mounting the evidence. Clin Microbiol Infect. 2019;25(5):536–537. doi:10.1016/j.cmi.2019.02.025
   PubMed Web of Science ®Google Scholar
• Yu X, Wang R, Peng W, et al. Incidence, distribution and clinical relevance of microbial contamination of preservation solution in deceased-donor kidney transplant recipients: a retrospective cohort study from China. Clin Microbiol Infect. 2019;25(5):595–600. doi:10.1016/j.cmi.2018.12.040
   PubMed Web of Science ®Google Scholar
• Oriol I, Sabé N, Tebé C, et al. Clinical impact of culture-positive preservation fluid on solid organ transplantation: a systematic review and meta-analysis. Transplant Rev. 2018;32(2):85–91. doi:10.1016/j.trre.2017.11.003
   Web of Science ®Google Scholar
• Corbel A, Ladrière M, Le Berre N, et al. Microbiological epidemiology of preservation fluids in transplanted kidney: a nationwide retrospective observational study. Clin Microbiol Infect. 2020;26(4):475–484. doi:10.1016/j.cmi.2019.07.018
   PubMed Web of Science ®Google Scholar
• Le Berre N, Ladrière M, Corbel A, et al. Antibiotic therapy in case of positive cultures of kidney transplant preservation fluid: a nationwide survey of prescribing practices. Eur J Clin Microbiol Infect Dis. 2020;39(5):915–921. doi:10.1007/s10096-019-03808-4
   PubMed Web of Science ®Google Scholar
• Addeo P, Saouli AC, Woehl-Jaegle ML, et al. Candida albicans arteritis transmitted by preservation fluid after liver transplantation. Ann Transpl. 2014;19:64–67. doi:10.12659/AOT.889831
   PubMed Web of Science ®Google Scholar
• Levesque E, Paugam-Burtz C, Saliba F, et al. Fungal complications after Candida preservation fluid contamination in liver transplant recipients. Transpl Int. 2015;28(11):1308–1316. doi:10.1111/tri.12633
   PubMed Web of Science ®Google Scholar
• Albano L, Bretagne S, Mamzer‐Bruneel M-F. Evidence that graft-site candidiasis after kidney transplantation is acquired during organ recovery: a multicenter study in France. Clin Infect Dis. 2009;48(2):194–202. doi:10.1086/595688
   PubMed Web of Science ®Google Scholar
• Rodríguez Faba O, Boissier R, Budde K, et al. European Association of Urology guidelines on renal transplantation: update 2018. Eur Urol Focus. 2018;4(2):208–215. doi:10.1016/j.euf.2018.07.014
   PubMedGoogle Scholar
• Bertrand D, Pallet N, Sartorius A, et al. Clinical and microbial impact of screening kidney allograft preservative solution for bacterial contamination with high-sensitivity methods. Transpl Int. 2013;26(8):795–799. doi:10.1111/tri.12130
   PubMed Web of Science ®Google Scholar
• Veroux M, Corona D, Scriffignano V, et al. Contamination of preservation fluid in kidney transplantation: single-center analysis. Transplant Process. 2010;42(4):1043–1045. doi:10.1016/j.transproceed.2010.03.041
   PubMed Web of Science ®Google Scholar
• Wakelin SJ, Casey J, Robertson A, et al. The incidence and importance of bacterial contaminants of cadaveric renal perfusion fluid. Transpl Int. 2005;17(11):680–686. doi:10.1007/s00147-004-0792-6
   PubMed Web of Science ®Google Scholar
• Meier-Kriesche HU, Ojo AO, Hanson JA, Kaplan B. Exponentially increased risk of infectious death in older renal transplant recipients. Kidney Int. 2001;59(4):1539–1543. doi:10.1046/j.1523-1755.2001.0590041539.x
   PubMed Web of Science ®Google Scholar
• Trouillhet I, Benito N, Cervera C, et al. Influence of age in renal transplant infections: cases and controls study. Transplantation. 2005;80(7):989–992. doi:10.1097/01.TP.0000173822.05877.D7
   PubMed Web of Science ®Google Scholar
• Bodro M, Sabe N, Tubau F, et al. Risk factors and outcomes of bacteremia caused by drug-resistant ESKAPE pathogens in solid-organ transplant recipients. Transplantation. 2013;96(9):843–849. doi:10.1097/TP.0b013e3182a049fd
   PubMed Web of Science ®Google Scholar
• Sandkovsky U, Kalil AC, Florescu DF. The use and value of procalcitonin in solid organ transplantation. Clin Transplant. 2015;29(8):689–696. doi:10.1111/ctr.12568
   PubMed Web of Science ®Google Scholar
• Strueber M, Warnecke G, Fuge J, et al. Everolimus versus mycophenolate mofetil De novo after lung transplantation: a prospective, randomized, open-label trial. Am J Transplant. 2016;16(11):3171–3180. doi:10.1111/ajt.13835
   PubMed Web of Science ®Google Scholar
• Sacher VY, Fertel D, Srivastava K, et al. Effects of prophylactic use of sirolimus on bronchiolitis obliterans syndrome development in lung transplant recipients. Ann Thorac Surg. 2014;97(1):268–274. doi:10.1016/j.athoracsur.2013.07.072
   PubMed Web of Science ®Google Scholar
• Snell GI, Valentine VG, Vitulo P, et al. Everolimus versus azathioprine in maintenance lung transplant recipients: an international, randomized, double-blind clinical trial. Am J Transplant. 2006;6(1):169–177. doi:10.1111/j.1600-6143.2005.01134.x
   PubMed Web of Science ®Google Scholar
• Bhorade S, Ahya VN, Baz MA, et al. Comparison of sirolimus with azathioprine in a tacrolimus-based immunosuppressive regimen in lung transplantation. Am J Respir Crit Care Med. 2011;183(3):379–387. doi:10.1164/rccm.201005-0775OC
   PubMed Web of Science ®Google Scholar
• Büchler M, Caillard S, Barbier S, et al. Sirolimus versus cyclosporine in kidney recipients receiving thymoglobulin, mycophenolate mofetil and a 6-month course of steroids. Am J Transplant. 2007;7(11):2522–2531. doi:10.1111/j.1600-6143.2007.01976.x
   PubMed Web of Science ®Google Scholar
• Kauffman HM, Cherikh WS, Cheng Y, et al. Maintenance immunosuppression with target-of-rapamycin inhibitors is associated with a reduced incidence of de novo malignancies. Transplantation. 2005;80(7):883–889. doi:10.1097/01.TP.0000184006.43152.8D
   PubMed Web of Science ®Google Scholar
• Vickers AJ, Holland F. Decision curve analysis to evaluate the clinical benefit of prediction models. Spine J. 2021;21(10):1643–1648. doi:10.1016/j.spinee.2021.02.024
   PubMed Web of Science ®Google Scholar